Aidan Synnott
Oncodesign Services has appointed Aidan Synnott as CEO
Read More
Author: Emily Kimber
MHRA approves prostate cancer imaging agent trofolastat
Approximately 55,100 new cases of prostate cancer are diagnosed every year in the UK
Read More
Regina Hodits
Angelini Ventures has appointed Regina Hodits as managing director
Read More
WHO adds first maternal RSV vaccine to prequalification list
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants
Read More
Elizabeth Holt
iOnctura has appointed Elizabeth Holt as Chief Business Officer
Read More- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
